PhRMA Reconsiders Medicare Stance For 2000: Incremental Reform Weighed
The linchpin legislative policy decision facing PhRMA for 2000 is whether to endorse an incremental drug benefit that stops short of comprehensive Medicare reform.
The linchpin legislative policy decision facing PhRMA for 2000 is whether to endorse an incremental drug benefit that stops short of comprehensive Medicare reform.